Multiple myeloma, The Lancet, vol.374, issue.9686, pp.324-339, 2009. ,
DOI : 10.1016/S0140-6736(09)60221-X
URL : https://hal.archives-ouvertes.fr/inserm-00130206
Latest advances and current challenges in the treatment of multiple myeloma, Nature Reviews Clinical Oncology, vol.364, issue.3, pp.135-143, 2012. ,
DOI : 10.1038/nrclinonc.2012.15
Anti-estrogens induce apoptosis of multiple myeloma cells, Blood, vol.92, issue.5, pp.1749-1457, 1998. ,
Estrogen receptors in human myeloma cells, Cancer Res, vol.60, issue.5, pp.1434-1441, 2000. ,
4-Hydroxytamoxifen Inhibits Proliferation of Multiple Myeloma Cells In vitro through Down-Regulation of c-Myc, Up-Regulation of p27Kip1, and Modulation of Bcl-2 Family Members, Clinical Cancer Research, vol.11, issue.6, pp.2345-2354, 2005. ,
DOI : 10.1158/1078-0432.CCR-04-1668
Raloxifene-Induced Myeloma Cell Apoptosis: A Study of Nuclear Factor-??B Inhibition and Gene Expression Signature, Molecular Pharmacology, vol.69, issue.5, pp.1615-1623, 2006. ,
DOI : 10.1124/mol.105.020479
Pure antiestrogen-induced G1-arrest in myeloma cells results from the reduced kinase activity of cyclin D3/CDK6 complexes whereas apoptosis is mediated by endoplasmic reticulum-dependent caspases, International Journal of Cancer, vol.2, issue.9, pp.2130-2141, 2008. ,
DOI : 10.1002/ijc.23310
Therapeutic potential of 12 Identiication and pharmacological characterization of cholesterol-5,6-epoxide hydrolase as a target of tamoxifen and AEBS ligands, Proc Natl Acad Sci, vol.107, issue.33, pp.13520-13525, 2010. ,
Cholesterol epoxide hydrolase and cancer, Current Opinion in Pharmacology, vol.12, issue.6, pp.696-703, 2012. ,
DOI : 10.1016/j.coph.2012.07.007
URL : https://hal.archives-ouvertes.fr/inserm-00743463
Ligands of the antiestrogen-binding site induce active cell death and autophagy in human breast cancer cells through the modulation of cholesterol metabolism, Cell Death and Differentiation, vol.66, issue.10, pp.1372-1384, 2009. ,
DOI : 10.1074/jbc.275.2.992
URL : https://hal.archives-ouvertes.fr/inserm-00519149
Effect of autophagy on multiple myeloma cell viability, Molecular Cancer Therapeutics, vol.8, issue.7, pp.1974-1984, 2009. ,
DOI : 10.1158/1535-7163.MCT-08-1177
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012, Cell Death and Differentiation, vol.94, issue.1, pp.107-120, 2012. ,
DOI : 10.1083/jcb.200712051
Guidelines for the use and interpretation of assays for monitoring autophagy, Autophagy, vol.4, issue.4, pp.445-544, 2012. ,
DOI : 10.4161/auto.6.4.12244
URL : https://hal.archives-ouvertes.fr/hal-01343085
5,6-Epoxy-cholesterols contribute to the anticancer pharmacology of Tamoxifen in breast cancer cells, Biochemical Pharmacology, vol.86, issue.1, 2013. ,
DOI : 10.1016/j.bcp.2013.02.031
URL : https://hal.archives-ouvertes.fr/inserm-00822322
Dual Inhibition of Akt/Mammalian Target of Rapamycin Pathway by Nanoparticle Albumin-Bound-Rapamycin and Perifosine Induces Antitumor Activity in Multiple Myeloma, Molecular Cancer Therapeutics, vol.9, issue.4, pp.963-975, 2010. ,
DOI : 10.1158/1535-7163.MCT-09-0763
Autophagy inhibition sensitizes multiple myeloma cells to 17-dimethylaminoethylamino-17-demethoxygeldanamycin-induced apoptosis, Leukemia Research, vol.34, issue.11, pp.1533-1538, 2010. ,
DOI : 10.1016/j.leukres.2010.07.002
Targeting autophagy to fight hematopoietic malignancies, Cell Cycle, vol.9, issue.17, pp.3470-3478, 2010. ,
DOI : 10.4161/cc.9.17.13048
Targeting NAD+ salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibition, Blood, vol.120, issue.17, pp.3519-3529, 2012. ,
DOI : 10.1182/blood-2012-03-416776
Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma, Oncogene, vol.21, issue.43, pp.6587-6597, 2002. ,
DOI : 10.1038/sj.onc.1205923
Chemoprevention of breast cancer with selective oestrogen-receptor modulators, Nature Reviews Cancer, vol.313, issue.1, pp.46-53, 2007. ,
DOI : 10.1038/nrc2048
Biological determinants of endocrine resistance in breast cancer, Nature Reviews Cancer, vol.10, issue.9, pp.631-643, 2009. ,
DOI : 10.1038/nrc2713
Estrogen receptor signaling as a target for novel breast cancer therapeutics, Biochemical Pharmacology, vol.85, issue.4, pp.449-465, 2013. ,
DOI : 10.1016/j.bcp.2012.10.018
URL : https://hal.archives-ouvertes.fr/inserm-00758201
Compromising the Unfolded Protein Response Induces Autophagy-Mediated Cell Death in Multiple Myeloma Cells, PLoS ONE, vol.6, issue.10, p.25820, 2011. ,
DOI : 10.1371/journal.pone.0025820.g007
The next generation proteasome inhibitors carfilzomib and oprozomib activate prosurvival autophagy via induction of the unfolded protein response and ATF4, Autophagy, vol.8, issue.12, pp.1873-1874, 2012. ,
DOI : 10.4161/auto.22185
Targeting Glucose Consumption and Autophagy in Myeloma with the Novel Nucleoside Analogue 8-Aminoadenosine, Journal of Biological Chemistry, vol.284, issue.39, pp.26816-26830, 2009. ,
DOI : 10.1074/jbc.M109.000646
Targeting Autophagy Augments In Vitro and In Vivo Antimyeloma Activity of DNA-Damaging Chemotherapy, Clinical Cancer Research, vol.17, issue.10, pp.3248-3258, 2011. ,
DOI : 10.1158/1078-0432.CCR-10-0890
Targeting autophagy to fight hematopoietic malignancies, Cell Cycle, vol.9, issue.17, pp.3470-3478, 2010. ,
DOI : 10.4161/cc.9.17.13048
Co-Inhibition of BCL-W and BCL2 Restores Antiestrogen Sensitivity through BECN1 and Promotes an Autophagy-Associated Necrosis, PLoS ONE, vol.41, issue.1, p.8604, 2010. ,
DOI : 10.1371/journal.pone.0008604.s005
A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines, Haematologica, vol.96, issue.4, pp.574-582, 2011. ,
DOI : 10.3324/haematol.2010.033456
URL : https://hal.archives-ouvertes.fr/inserm-00550232
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review, Leukemia, vol.91, issue.12, pp.2210-2221, 2009. ,
DOI : 10.1016/j.beha.2007.08.004
New insights into the regulation of human B-cell differentiation, Trends in Immunology, vol.30, issue.6, pp.277-285, 2009. ,
DOI : 10.1016/j.it.2009.03.008
Cholesterol epoxide hydrolase and cancer, Current Opinion in Pharmacology, vol.12, issue.6, pp.696-703, 2012. ,
DOI : 10.1016/j.coph.2012.07.007
URL : https://hal.archives-ouvertes.fr/inserm-00743463
Identification of 5??,6??-Epoxycholesterol as a Novel Modulator of Liver X Receptor Activity, Molecular Pharmacology, vol.78, issue.6, pp.1046-1058, 2010. ,
DOI : 10.1124/mol.110.065193
The oxysterol receptor LXR inhibits proliferation of human breast cancer cells, Carcinogenesis, vol.30, issue.4, pp.575-579, 2009. ,
DOI : 10.1093/carcin/bgp029
Gene expression profiling of B lymphocytes and plasma cells from Waldenstr??m's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals, Leukemia, vol.21, issue.3, pp.541-549, 2007. ,
DOI : 10.1038/sj.leu.2404520
Niemann???Pick C2 (NPC2) and intracellular cholesterol trafficking, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol.1791, issue.7, pp.671-678, 2009. ,
DOI : 10.1016/j.bbalip.2009.02.001
Defective cholesterol trafficking in Niemann-Pick C-deficient cells, FEBS Letters, vol.51, issue.13, pp.2731-2739, 2010. ,
DOI : 10.1016/j.febslet.2010.04.047
Regulation of lipid stores and metabolism by lipophagy, Cell Death and Differentiation, vol.42, issue.1, pp.3-11, 2013. ,
DOI : 10.1371/journal.pone.0025269
An Emerging Role of mTOR in Lipid Biosynthesis, Current Biology, vol.19, issue.22, pp.1046-1052, 2009. ,
DOI : 10.1016/j.cub.2009.09.058
The multifaceted role of mTORC1 in the control of lipid metabolism, EMBO reports, vol.106, issue.3, pp.242-251, 2013. ,
DOI : 10.1126/scisignal.267pe24
Synthesis, binding and structure???affinity studies of new ligands for the microsomal anti-estrogen binding site (AEBS), Bioorganic & Medicinal Chemistry, vol.8, issue.8, pp.2007-2016, 2000. ,
DOI : 10.1016/S0968-0896(00)00119-X
URL : https://hal.archives-ouvertes.fr/inserm-00090778
Distinct Classes of Phosphatidylinositol 3'-Kinases Are Involved in Signaling Pathways That Control Macroautophagy in HT-29 Cells, Journal of Biological Chemistry, vol.275, issue.2, pp.992-998, 2000. ,
DOI : 10.1074/jbc.275.2.992
Microsomal antiestrogen-binding site ligands induce growth control and differentiation of human breast cancer cells through the modulation of cholesterol metabolism, Molecular Cancer Therapeutics, vol.7, issue.12, pp.3707-3718, 2008. ,
DOI : 10.1158/1535-7163.MCT-08-0507